Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dostinex for OHSS Prevention and Pregnancy Outcome in ICSI
NCT02306564Phase 3Unknown
- Sponsor
- Kasr Al Ainy Hospital
- Start
- Dec 2014
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cabergoline in ovarian hyperstimulation syndrome (OHSS), sponsored by Kasr Al Ainy Hospital. Status: unknown.
02
Drugs
cabergoline
03
Conditions
ovarian hyperstimulation syndrome (OHSS)
Beyond the preview
Go deeper on NCT02306564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02306564.